These findings suggest that AT1R, as well as VEGF, may become a prognostic marker for ovarian cancer patients; however, our multivariate analyses showed that FIGO stage and VEGF, but not AT1R, were independent prognostic factors for both OS and PFS. This evidence concerns the gene VEGFA and ovarian carcinoma.